We have performed a prospective, randomized, double-blind clinical study to assess the efficacy of ondansetron, droperidol, or both, in preventing postoperative emesis. We studied 242 patients undergoing biliary or gynaecological surgery under general anaesthesia. Shortly before induction of anaesthesia, patients received: saline i.v. (group 1, nϭ62); droperidol 2.5 mg i.v. (group 2, nϭ60); ondansetron 4 mg i.v. (group 3, nϭ57); or droperidol 2.5 mg with ondansetron 4 mg i.v. (group 4, nϭ63). Nausea occurred in 45%, 37%, 32% and 29% (Pϭ0.234) and vomiting in 23%, 17%, 9% and 5% (Pϭ0.016) of patients in groups 1, 2, 3 and 4, respectively, during the first 24 h. Groups 2 and 4 had greater sedation scores than group 1 during the first 3 h (PϽ0.01). We conclude that both droperidol and ondansetron showed a significant antiemetic effect, ondansetron was not significantly better than droperidol, and the combination of droperidol and ondansetron was better than droperidol but no better than ondansetron alone.
Ondansetron, a 5-hydroxytryptamine type 3 (5-HT 3 ) recep-with thiopental 4-6 mg kg -1 , fentanyl up to 3 µg kg -1 and vecuronium 0.1 mg kg -1 , and the trachea intubated. A tor antagonist and droperidol, a dopamine antagonist, have gastric tube was inserted and gastric contents aspirated. been shown to be safe and useful for the prevention and Anaesthesia was maintained with isoflurane and 50% nitrous treatment of postoperative emesis. 1 By acting via different oxide in oxygen. At the end of surgery, neostigmine and receptors in the chemoreceptor trigger zone, the efficacy of atropine were given to antagonize residual neuromuscular both drugs could be greater if used together. block, the trachea was extubated and the gastric tube We have assessed the efficacy and adverse effects of withdrawn. Postoperative analgesia was achieved with ondansetron, droperidol, or both, in the prevention of ketorolac 30 mg i.v. qid, and morphine 2 mg i.v. on postoperative emesis in patients undergoing intra-abdominal request. No other sedative drugs were given during the first surgical procedures under general anaesthesia.
postoperative day. Nausea and vomiting were assessed at 1, 2, 3, 6, 9, 12
Methods and results
and 24 h in the postoperative period, in addition to sedation We studied prospectively 242 ASA I or II patients, aged (0ϭawake; 1ϭdrowsy; 2ϭasleep, responds to verbal com-18-60 yr, undergoing elective gynaecological or biliary mands; 3ϭasleep, responds to physical stimulus). Pain was surgical procedures, either by laparatomy or laparoscopy. assessed at 6, 12 and 24 h using a 10-cm visual analogue Patients were given midazolam 7.5 mg orally the night scale, and analgesic requirements were consigned. before and 90 min before arrival in the operating room.
Statistical analysis included chi-square and KruskalBefore induction of anaesthesia, patients were allocated by Wallis tests to compare nausea and vomiting, and ANOVA, random numbers to receive saline i.v. (group 1, control, nϭ Kruskal-Wallis and chi-square tests for comparison of 62), droperidol 2.5 mg i.v. (group 2, nϭ60), ondansetron patient data, analgesic requirements, pain and sedation level. 4 mg i.v. (group 3, nϭ57) or droperidol 2.5 mg with There were no differences between groups in patient ondansetron 4 mg i.v. (group 4, nϭ63). The syringes were data, type of surgery or previous history of sickness. During coded and the anaesthetist and investigator were blinded to the first 24 h, the incidence of nausea was 18%, 29% and 36% less frequent in groups 2, 3 and 4, respectively, the drug administered. General anaesthesia was induced compared with group 1, but this was not statistically ondansetron compared with droperidol but not with ondansetron alone. Adding droperidol to ondansetron did not increase significant ( Table 1 ). The incidence of vomiting in patients its effectiveness but increased drowsiness significantly. Our receiving droperidol, ondansetron and ondansetron with data are consistent with those of Belo and Koutsoukos who droperidol in the first 24 h was reduced by 26%, 61% and found no differences between the combination of ondansetron 78%, respectively, compared with group 1 (P ϭ 0.016). At 4 mg and droperidol 1.25 mg and each drug alone in 80 24 h, both droperidol and ondansetron showed a significant women undergoing gynaecological sugery. 6 However, our antiemetic effect compared with controls, ondansetron was data contrast with those of Pueyo and colleagues, who studied not significantly better than droperidol, and the combination 100 patients subjected to abdominal surgery and found that of droperidol and ondansetron was significantly better than the combination of ondansetron 4 mg and droperidol 2.5 mg droperidol but no better than ondansetron alone.
was superior to each antiemetic alone and to a control group. 7 Compared with patients in group 1, mean sedation scores Despite a similar antiemetic regimen in our study and that of were significantly higher during the first 3 h after operation Pueyo and colleagues there were some differences in study in those receiving droperidol and droperidol with design. Pueyo and colleagues used two doses of the antiondansetron. There was no difference between groups in emetic, given 12 h apart, and higher doses of morphine were pain scores or morphine requirements during the first administered. This may explain the higher incidence of postoperative day. There were no cases of profound sedation, emesis in the control group. This higher incidence makes any or pulmonary or cardiovascular complications.
difference between groups easier to demonstrate. Although the sample size in our study was larger than that of Pueyo and Comment colleagues, a type II error cannot be excluded, particularly because of the low incidence of vomiting in our study. Because antiemetic drugs have several mechanisms of action, it seems reasonable to combine drugs to obtain a References greater antiemetic action. In chemotherapy-induced emesis, Our data confirmed the additive effect of droperidol and
